MedTrace Logo

Effect of Nutritional Counseling Associated With Transcranial Direct-current Stimulation in Binge Eating Reduction

NCT04226794 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-12-28

No results posted yet for this study

Summary

Binge eating disorder is the most prevalent eating disorder, with consequences not only economic but also social. It is related to a set of cognitive alterations related to impulsivity, cognitive function, attention, decision making, emotional control and physiological alterations in the Central nervous system (CNS) in the processing of rewards, mainly in the frontal cortical regions. Psychotherapies are the standard reference treatments, with Cognitive Behavioral Therapy (CBT) being the most indicated nonpharmacological intervention. However, the avoidance rates and the rates of non responders to treatment are significant. In view of this, it is believed that therapeutic approaches aimed at the modulation of the CNS, such as Transcranial direct-current stimulation (tDCS) may have a beneficial effect on the neurobiology of the processes that govern these disorders, thus adding to the effects of CBT and amplifying the therapeutic response.

Conditions

  • Transcranial Direct Current Stimulation
  • Binge-Eating Disorder
  • Cognitive Behavioral Therapy

Interventions

DEVICE

a-tDCS

Anodal Transcranial direct current stimulation (tDCS) stimulation. Anode will be allocated at DLPFC right and cathode at DLPFC left. The stimulation will occur for 20 min in the intensity of 2 milliampere (mA).

BEHAVIORAL

Nutritional Counseling

Presentation delivered through video clip during 20 minutes based on Cognitive Behavioral Therapy interventions

COMBINATION_PRODUCT

a-tDCS and nutritional counseling

a-tDCS + Nutritional Counseling

COMBINATION_PRODUCT

s-tDCS and nutritional counseling

s-tDCS + Nutritional Counseling

Sponsors & Collaborators

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Wolnei Caumo, PHD · UFRGS and Hospital de Clínicas de Porto Alegre (HCPA)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-10
Primary Completion
2021-12-21
Completion
2023-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04226794 on ClinicalTrials.gov